EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut dysbiosis contributes to the development of Budd-Chiari syndrome through immune imbalance

Qinwei Lu, Rongtao Zhu, Lin Zhou, Ruifang Zhang, Zhen Li, Peng Xu, Zhiwei Wang, Gang Wu, Jianzhuang Ren, Dechao Jiao, Yan Song, Jian Li und 4 weitere

mSystems · 2024

DOI: 10.1128/msystems.00794-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, 2024. Verfasst von Qinwei Lu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Dysbiosis, Gastrointestinal Microbiome, Budd-Chiari Syndrome, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Key science and technology project s of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Budd-Chiari syndrome (B-CS) is a rare and lethal condition characterized by hepatic venous outflow tract blockage. Gut microbiota has been linked to numerous hepatic disorders, but its significance in B-CS pathogenesis is uncertain. First, we performed a case-control study ( N case = 140, N control = 63) to compare the fecal microbiota of B-CS and healthy individuals by metagenomics sequencing. B-CS patients’ gut microbial composition and activity changed significantly, with a different metagenomic makeup, increased potentially pathogenic bacteria, including Prevotella , and disease-linked microbial function. Imbalanced cytokines in patients were demonstrated to be associated with gut dysbiosis, which led us to suspect that B-CS is associated with gut microbiota and immune dysregulation. Next, 16S ribosomal DNA sequencing on fecal microbiota transplantation (FMT) mice models examined the link between gut dysbiosis and B-CS. FMT models showed damaged liver tissues, posterior inferior vena cava, and increased Prevotella in the disturbed gut microbiota of FMT mice. Notably, B-CS-FMT impaired the morphological structure of colonic tissues and increased intestinal permeability. Furthermore, a significant increase of the same cytokines (IL-5, IL-6, IL-9, IL-10, IL-17A, IL-17F, and IL-13) and endotoxin levels in B-CS-FMT mice were observed. Our study suggested that gut microbial dysbiosis may cause B-CS through immunological dysregulation. IMPORTANCE This study revealed that gut microbial dysbiosis may cause Budd-Chiari syndrome (B-CS). Gut dysbiosis enhanced intestinal permeability, and toxic metabolites and imbalanced cytokines activated the immune system. Consequently, the escalation of causative factors led to their concentration in the portal vein, thereby compromising both the liver parenchyma and outflow tract. Therefore, we proposed that gut microbial dysbiosis induced immune imbalance by chronic systemic inflammation, which contributed to the B-CS development. Furthermore, Prevotella may mediate inflammation development and immune imbalance, showing potential in B-CS pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisGastrointestinal MicrobiomeBudd-Chiari SyndromeCytokinesHumansAnimalsMiceMaleCase-Control StudiesFemaleAdultFecal Microbiota TransplantationMiddle Aged

Stichwörter der Autor:innen

Budd-Chiari syndromefecal microbiota transplantationgut microbiotagut microbiota dysbiosisimmune imbalance

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Institute of Hepatobiliary and Pancreatic Diseases, Zhengzhou University, Zhengzhou, China.
  • Key Lab of Hepatobiliary and Pancreatic Diseases, Zhengzhou, China.
  • Department of Gastroenterology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Ultrasound Diagnosis, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Endovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Yuling Sun

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Key science and technology project s of Henan Province

Zitieren

APA

Lu, Q., Zhu, R., Zhou, L., Zhang, R., Li, Z., Xu, P., Wang, Z., Wu, G., Ren, J., Jiao, D., Song, Y., Li, J., Wang, W., Liang, R., Ma, X., & Sun, Y. (2024). Gut dysbiosis contributes to the development of Budd-Chiari syndrome through immune imbalance. mSystems. https://doi.org/10.1128/msystems.00794-24

Vancouver

Lu Q, Zhu R, Zhou L, Zhang R, Li Z, Xu P, et al. Gut dysbiosis contributes to the development of Budd-Chiari syndrome through immune imbalance. mSystems. 2024. doi:10.1128/msystems.00794-24

BibTeX
@article{Lu2024,
  author = {Lu, Qinwei and Zhu, Rongtao and Zhou, Lin and Zhang, Ruifang and Li, Zhen and Xu, Peng and Wang, Zhiwei and Wu, Gang and Ren, Jianzhuang and Jiao, Dechao and Song, Yan and Li, Jian and Wang, Weijie and Liang, Ruopeng and Ma, Xiuxian and Sun, Yuling},
  title = {Gut dysbiosis contributes to the development of Budd-Chiari syndrome through immune imbalance},
  journal = {mSystems},
  year = {2024},
  doi = {10.1128/msystems.00794-24}
}
Kostenlos starten →